Metabolomics of Breast Cancer: A Review.

breast cancer glycolysis metabolites metabolomics

Journal

Metabolites
ISSN: 2218-1989
Titre abrégé: Metabolites
Pays: Switzerland
ID NLM: 101578790

Informations de publication

Date de publication:
13 Jul 2022
Historique:
received: 25 06 2022
revised: 09 07 2022
accepted: 11 07 2022
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 28 7 2022
Statut: epublish

Résumé

Breast cancer is the most commonly diagnosed cancer in women worldwide. Major advances have been made towards breast cancer prevention and treatment. Unfortunately, the incidence of breast cancer is still increasing globally. Metabolomics is the field of science which studies all the metabolites in a cell, tissue, system, or organism. Metabolomics can provide information on dynamic changes occurring during cancer development and progression. The metabolites identified using cutting-edge metabolomics techniques will result in the identification of biomarkers for the early detection, diagnosis, and treatment of cancers. This review briefly introduces the metabolic changes in cancer with particular focus on breast cancer.

Identifiants

pubmed: 35888767
pii: metabo12070643
doi: 10.3390/metabo12070643
pmc: PMC9325024
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Front Oncol. 2020 Dec 22;10:537930
pubmed: 33415069
PLoS One. 2018 Feb 13;13(2):e0190958
pubmed: 29438405
Clin Chem. 2013 Jan;59(1):138-46
pubmed: 23150057
Nat Rev Drug Discov. 2008 Jun;7(6):489-503
pubmed: 18511927
Pediatr Res. 2022 Jun;91(7):1864-1873
pubmed: 34526650
Int J Mol Sci. 2022 May 10;23(10):
pubmed: 35628139
J Natl Cancer Inst. 2004 Dec 15;96(24):1805-6
pubmed: 15601632
Int J Cancer. 2015 Apr 1;136(7):1619-28
pubmed: 25155347
Br J Cancer. 2020 Jan;122(2):150-156
pubmed: 31819187
J Pharm Biomed Anal. 2019 Feb 5;164:421-429
pubmed: 30445355
Front Cell Dev Biol. 2021 Jul 26;9:703218
pubmed: 34381785
Int J Mol Sci. 2018 Mar 19;19(3):
pubmed: 29562706
Oncogene. 2016 Jun 16;35(24):3201-8
pubmed: 26455325
Front Med (Lausanne). 2018 Mar 12;5:61
pubmed: 29662881
J Pharm Biomed Anal. 2018 Oct 25;160:38-45
pubmed: 30059813
Nat Med. 2019 May;25(5):850-860
pubmed: 31068703
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Cell Metab. 2020 Jun 2;31(6):1154-1172.e9
pubmed: 32492394
Mol Cell. 2016 Jan 21;61(2):210-21
pubmed: 26774282
Nat Rev Cancer. 2016 Nov;16(11):732-749
pubmed: 27658529
Linacre Q. 2014 Aug;81(3):244-77
pubmed: 25249706
J Proteome Res. 2018 Jan 5;17(1):337-347
pubmed: 29110491
Nature. 2011 Nov 20;481(7381):380-4
pubmed: 22101433
Nat Rev Mol Cell Biol. 2016 Jul;17(7):451-9
pubmed: 26979502
Science. 2012 May 25;336(6084):1040-4
pubmed: 22628656
Circ Cardiovasc Genet. 2017 Apr;10(2):
pubmed: 28360086
Eur J Med Chem. 2021 Jan 15;210:112980
pubmed: 33176943
J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Sep 1;1000:95-104
pubmed: 26218769
JCI Insight. 2017 Feb 23;2(4):e87489
pubmed: 28239646
BMC Cancer. 2018 May 5;18(1):532
pubmed: 29728083
BMC Cancer. 2016 Jun 01;16:343
pubmed: 27246354
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
J Tradit Chin Med. 2014 Apr;34(2):166-72
pubmed: 24783928
Breast Cancer Res Treat. 2021 Nov;190(1):53-67
pubmed: 34448090
Front Endocrinol (Lausanne). 2019 Jan 09;9:790
pubmed: 30687233
Biol Pharm Bull. 2016;39(7):1179-86
pubmed: 27374292
J Clin Lab Anal. 2022 Feb;36(2):e24212
pubmed: 34994982
Lancet. 2017 Feb 25;389(10071):847-860
pubmed: 27814965
Nutrients. 2022 May 10;14(10):
pubmed: 35631131
Tumour Biol. 2015 Jul;36(7):5473-83
pubmed: 25683484
J Pathol. 2013 Aug;230(4):350-5
pubmed: 23729358
JAMA. 2017 Jun 20;317(23):2402-2416
pubmed: 28632866
Onco Targets Ther. 2016 Mar 11;9:1389-98
pubmed: 27042107
Front Oncol. 2020 Mar 06;10:317
pubmed: 32211335
Cancer Genomics Proteomics. 2014 Nov-Dec;11(6):279-94
pubmed: 25422359
Nat Med. 2011 Oct 30;17(11):1498-503
pubmed: 22037646
BMC Cancer. 2010 Nov 16;10:628
pubmed: 21080935
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Nature. 2000 Aug 17;406(6797):747-52
pubmed: 10963602
JAMA. 1993 Jul 21;270(3):338-43
pubmed: 8123079
Trends Biochem Sci. 2018 Oct;43(10):752-789
pubmed: 30177408
Cancer Causes Control. 2014 Feb;25(2):143-9
pubmed: 24186145
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Breast Cancer Res Treat. 2011 Jan;125(2):421-30
pubmed: 20352489
Iran J Basic Med Sci. 2020 Feb;23(2):186-194
pubmed: 32405361
Breast Cancer Res Treat. 2019 Oct;177(3):591-601
pubmed: 31286302
Cancer Sci. 2018 Jul;109(7):2315-2326
pubmed: 29737597
Anal Biochem. 2015 Nov 1;488:14-8
pubmed: 26247715
Cell Death Dis. 2017 Feb 2;8(2):e2593
pubmed: 28151470
Front Oncol. 2021 May 31;11:630672
pubmed: 34136379
J Cell Biochem. 2011 Apr;112(4):1084-92
pubmed: 21308737
Biotechnol Prog. 2008 Mar-Apr;24(2):334-41
pubmed: 18307352
Cancer Res. 2011 May 1;71(9):3236-45
pubmed: 21415164
Oncotarget. 2018 Feb 7;9(14):11677-11690
pubmed: 29545929
Cancer Res. 2010 Mar 15;70(6):2397-405
pubmed: 20197471
Cell Metab. 2012 Jan 4;15(1):110-21
pubmed: 22225880
PLoS One. 2013 Apr 17;8(4):e61578
pubmed: 23613877
BMC Med. 2016 Jan 28;14:13
pubmed: 26817443
Int J Biol Sci. 2017 Nov 1;13(11):1387-1397
pubmed: 29209143
Mol Oncol. 2010 Jun;4(3):192-208
pubmed: 20452298
Br J Cancer. 2020 Jan;122(1):4-22
pubmed: 31819192
Mol Oncol. 2013 Jun;7(3):297-307
pubmed: 23142658
Oncotarget. 2017 Mar 21;8(12):19522-19533
pubmed: 28076849
Front Oncol. 2020 May 19;10:804
pubmed: 32509585
J Breast Health. 2015 Apr 1;11(2):59-66
pubmed: 28331693
Cell Metab. 2020 Jan 7;31(1):62-76
pubmed: 31813823
Metabolomics. 2013;9(5):960-973
pubmed: 24039617
Cureus. 2018 Feb 26;10(2):e2235
pubmed: 29713580
Trends Biotechnol. 1998 Sep;16(9):373-8
pubmed: 9744112
Metabolomics. 2018 Feb 14;14(3):33
pubmed: 30830360
Br J Cancer. 2005 Oct 31;93(9):1046-52
pubmed: 16175185
Cancer Biol Ther. 2010 Nov 15;10(10):955-60
pubmed: 21057215
EBioMedicine. 2017 Jul;21:37-44
pubmed: 28648985
Nature. 2018 Feb 15;554(7692):378-381
pubmed: 29414946
Am J Epidemiol. 2000 Nov 15;152(10):950-64
pubmed: 11092437
NMR Biomed. 2012 Nov;25(11):1271-9
pubmed: 22407957
Nature. 2017 Apr 19;544(7650):372-376
pubmed: 28425994
Int J Environ Res Public Health. 2020 Jul 07;17(13):
pubmed: 32645841
Breast Cancer Res. 2014 Aug 05;16(4):415
pubmed: 25091696
Adv Biol Regul. 2016 Sep;62:11-17
pubmed: 26838061
Biochim Biophys Acta. 2016 Oct;1863(10):2422-35
pubmed: 26828774
Oncogenesis. 2022 Apr 14;11(1):17
pubmed: 35422484
Trends Endocrinol Metab. 2019 Jun;30(6):357-368
pubmed: 31040047
Arch Gynecol Obstet. 2022 Apr 25;:
pubmed: 35467121
J Natl Cancer Inst. 2015 Jun 10;107(9):
pubmed: 26063794
Cancer Causes Control. 2018 Jul;29(7):611-618
pubmed: 29846844
Cells. 2021 Apr 13;10(4):
pubmed: 33924316
Nat Commun. 2020 Aug 21;11(1):4205
pubmed: 32826891
Biochim Biophys Acta. 2012 May;1821(5):852-7
pubmed: 21979150
Cells. 2019 Mar 29;8(4):
pubmed: 30934972
J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Jan 15;1105:26-37
pubmed: 30562627
J Am Soc Mass Spectrom. 2016 Dec;27(12):1897-1905
pubmed: 27624161
Ultrasonography. 2016 Oct;35(4):281-8
pubmed: 27599892
PLoS One. 2012;7(7):e40199
pubmed: 22815728
BMC Med. 2019 Sep 24;17(1):178
pubmed: 31547832
Cell Stem Cell. 2018 Feb 1;22(2):206-220.e4
pubmed: 29395055
Nat Rev Cancer. 2016 Oct;16(10):619-34
pubmed: 27492215
Cell Metab. 2018 Jan 9;27(1):136-150.e5
pubmed: 29249690
J Med Life. 2015;8(Spec Iss 4):6-11
pubmed: 28316699
Cell Rep. 2014 May 22;7(4):1248-58
pubmed: 24813884
Ann Oncol. 2012 Aug;23 Suppl 6:vi7-12
pubmed: 23012306
Genome Med. 2016 Mar 31;8(1):34
pubmed: 27036109
Front Cell Dev Biol. 2021 Jan 12;8:603837
pubmed: 33511116
Adv Exp Med Biol. 2019;1148:173-199
pubmed: 31482500
J Natl Cancer Inst. 2014 Apr 28;106(5):
pubmed: 24777111
Analyst. 2017 Jun 7;142(11):2038-2049
pubmed: 28497155
J Inherit Metab Dis. 2018 May;41(3):329-336
pubmed: 29663269
Science. 1986 Apr 4;232(4746):34-47
pubmed: 3513311
Anticancer Res. 2005 Nov-Dec;25(6C):4487-92
pubmed: 16334131
Metabolomics. 2010 Mar;6(1):78-95
pubmed: 20300169
Cancer Res. 2015 May 1;75(9):1782-8
pubmed: 25855379
NPJ Breast Cancer. 2021 Sep 24;7(1):129
pubmed: 34561446
Geriatrics (Basel). 2020 Nov 19;5(4):
pubmed: 33228041
Pathobiology. 2015 Sep;82(3-4):153-65
pubmed: 26330356
N Engl J Med. 2001 Feb 22;344(8):539-48
pubmed: 11207349

Auteurs

Ramadevi Subramani (R)

Center of Emphasis in Cancer, Department of Molecular and Translation Medicine, Paul L. Foster School of Medicine, Texas Tech Health Science Center El Paso, El Paso, TX 79905, USA.
L. Frederick Francis Graduate School of Biomedical Sciences, Texas Tech Health Science Center El Paso, El Paso, TX 79905, USA.

Seeta Poudel (S)

Center of Emphasis in Cancer, Department of Molecular and Translation Medicine, Paul L. Foster School of Medicine, Texas Tech Health Science Center El Paso, El Paso, TX 79905, USA.

Kenneth D Smith (KD)

L. Frederick Francis Graduate School of Biomedical Sciences, Texas Tech Health Science Center El Paso, El Paso, TX 79905, USA.

Adriana Estrada (A)

Center of Emphasis in Cancer, Department of Molecular and Translation Medicine, Paul L. Foster School of Medicine, Texas Tech Health Science Center El Paso, El Paso, TX 79905, USA.

Rajkumar Lakshmanaswamy (R)

Center of Emphasis in Cancer, Department of Molecular and Translation Medicine, Paul L. Foster School of Medicine, Texas Tech Health Science Center El Paso, El Paso, TX 79905, USA.
L. Frederick Francis Graduate School of Biomedical Sciences, Texas Tech Health Science Center El Paso, El Paso, TX 79905, USA.

Classifications MeSH